A phase IIa trial of the new tuberculosis vaccine, MVA85A, in HIV- and/or Mycobacterium tuberculosis-infected adults.

A phase IIa trial of the new tuberculosis vaccine, MVA85A, in HIV- and/or Mycobacterium tuberculosis-infected adults.

RATIONALE: Novel tuberculosis (TB) vaccines should be safe and effective in populations infected with Mycobacterium tuberculosis (M.tb) and/or HIV for effective TB control. OBJECTIVE: To determine the safety and immunogenicity of MVA85A, a novel TB vaccine, among M.tb- and/or HIV-infected persons in...

Full description

Bibliographic Details
Main Authors:	Scriba, T, Tameris, M, Smit, E, van der Merwe, L, Hughes, E, Kadira, B, Mauff, K, Moyo, S, Brittain, N, Lawrie, A, Mulenga, H, de Kock, M, Makhethe, L, Janse van Rensburg, E, Gelderbloem, S, Veldsman, A, Hatherill, M, Geldenhuys, H, Hill, A, Hawkridge, A, Hussey, G, Hanekom, W, McShane, H, Mahomed, H
Format:	Journal article
Language:	English
Published:	2012

Similar Items

Dose-finding study of the novel tuberculosis vaccine, MVA85A, in healthy BCG-vaccinated infants.
by: Scriba, T, et al.
Published: (2011)

Safety and immunogenicity of a new tuberculosis vaccine, MVA85A, in healthy adults in South Africa.
by: Hawkridge, T, et al.
Published: (2008)

The role of clinical symptoms in the diagnosis of intrathoracic tuberculosis in young children
by: Mcshane, H, et al.
Published: (2015)

Modified vaccinia Ankara-expressing Ag85A, a novel tuberculosis vaccine, is safe in adolescents and children, and induces polyfunctional CD4+ T cells.
by: Scriba, T, et al.
Published: (2010)

Risk of disease after isoniazid preventive therapy for mycobacterium tuberculosis exposure in young HIV uninfected children
by: Mcshane, H, et al.
Published: (2015)

Lessons learnt from the first efficacy trial of a new infant tuberculosis vaccine since BCG.
by: Tameris, M, et al.
Published: (2013)

Lessons learnt from the first efficacy trial of a new infant tuberculosis vaccine since BCG
by: Tameris, M, et al.
Published: (2013)

Human newborn bacille Calmette–Guérin vaccination and risk of tuberculosis disease: a case-control study
by: Fletcher, H, et al.
Published: (2016)

Elevated IgG responses in infants are associated with reduced prevalence of Mycobacterium tuberculosis infection
by: Logan, E, et al.
Published: (2018)

Serial QuantiFERON testing and tuberculosis disease risk among young children: an observational cohort study
by: Andrews, J, et al.
Published: (2017)

Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial.
by: Tameris, MD, et al.
Published: (2013)

Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: A randomised, placebo-controlled phase 2b trial
by: Tameris, MD, et al.
Published: (2013)

Effects of MVA85A vaccine on tuberculosis challenge in animals: systematic review
by: Mcshane, H, et al.
Published: (2016)

Heterologous vaccination against human tuberculosis modulates antigen-specific CD4+ T-cell function.
by: Dintwe, O, et al.
Published: (2013)

Inflammation and immune activation are associated with risk of Mycobacterium tuberculosis infection in BCG-vaccinated infants
by: Satti, I, et al.
Published: (2022)

Impact of isoniazid preventive therapy on the evaluation of long-term effectiveness of infant MVA85A vaccination
by: Bunyasi, E, et al.
Published: (2017)

A New Vaccine for Tuberculosis: The Challenges of Development and Deployment
by: Fletcher, H, et al.
Published: (2009)

The candidate TB vaccine, MVA85A, induces highly durable Th1 responses.
by: Tameris, M, et al.
Published: (2014)

Comparison of haematology and biochemistry parameters in healthy South African infants with laboratory reference intervals.
by: Schmidt, B, et al.
Published: (2017)

The candidate TB vaccine, MVA85A, induces highly durable Th1 responses
by: Tameris, M, et al.
Published: (2014)

Safety and immunogenicity of newborn MVA85A vaccination and selective, delayed Bacille Calmette-Guerin (BCG) for infants of HIV infected mothers: A phase 2 randomized controlled trial.
by: Nemes, E, et al.
Published: (2017)

Clinical testing of tuberculosis vaccine candidates
by: Hatherill, M, et al.
Published: (2016)

A comparison of IFNgamma detection methods used in tuberculosis vaccine trials.
by: Beveridge, N, et al.
Published: (2008)

Tuberculosis is changing
by: Walker, T, et al.
Published: (2017)

Antibodies and tuberculosis
by: Jacobs, A, et al.
Published: (2016)

Vaccines for tuberculosis
by: McShane, H
Published: (2013)

The SIGLEC14 null allele is associated with Mycobacterium tuberculosis- and BCG-induced clinical and immunologic outcomes
by: Graustein, A, et al.
Published: (2017)

Tuberculosis vaccines: progress and challenges.
by: Checkley, A, et al.
Published: (2011)

Tuberculosis vaccines: present and future.
by: Minassian, A, et al.
Published: (2008)

Undiagnosed pulmonary tuberculosis among prisoners in Malaysia: an overlooked risk for tuberculosis in the community
by: Al-Darraji, H.A.A., et al.
Published: (2016)

Tuberculosis vaccines: Progress and challenges
by: Checkley, A, et al.
Published: (2011)

Human and Bovine Tuberculosis
by: McShane, H
Published: (2016)

The future of vaccines for tuberculosis
by: Stockdale, L, et al.
Published: (2019)

Immunological outcomes of new tuberculosis vaccine trials: WHO panel recommendations.
by: Hanekom, W, et al.
Published: (2008)

Process of Assay Selection and Optimization for the Study of Case and Control Samples from a Phase IIb Efficacy Trial of a Candidate Tuberculosis Vaccine, MVA85A
by: Harris, SA, et al.
Published: (2014)

Immunological outcomes of new tuberculosis vaccine trials: WHO panel recommendations
by: Hanekom, W, et al.
Published: (2008)

Prime-boost immunisation strategies for tuberculosis.
by: Mcshane, H, et al.
Published: (2005)

Tuberculosis vaccine promises sterilizing immunity.
by: Mcshane, H, et al.
Published: (2011)

Safety and immunogenicity of a new tuberculosis vaccine, MVA85A, in Mycobacterium tuberculosis-infected individuals.
by: Sander, C, et al.
Published: (2009)

Generation and analysis of attack graphs on computer networks
by: Janse van Rensburg, A
Published: (2018)